A prospective evaluation of early detection biomarkers for ovarian cancer in the European EPIC cohort

PURPOSE: About 60% of ovarian cancers are diagnosed at late stage, when 5-year survival is less than 30% in contrast to 90% for local disease. This has prompted search for early detection biomarkers. For initial testing, specimens taken months or years before ovarian cancer diagnosis are the best so...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Clin Cancer Res
Autori principali: Terry, Kathryn L., Schock, Helena, Fortner, Renée T., Hüsing, Anika, Fichorova, Raina N., Yamamoto, Hidemi S., Vitonis, Allison F., Johnson, Theron, Overvad, Kim, Tjønneland, Anne, Boutron-Ruault, Marie-Christine, Mesrine, Sylvie, Severi, Gianluca, Dossus, Laure, Rinaldi, Sabina, Boeing, Heiner, Benetou, Vassiliki, Lagiou, Pagona, Trichopoulou, Antonia, Krogh, Vittorio, Kuhn, Elisabetta, Panico, Salvatore, Bueno-de-Mesquita, H. Bas, Onland-Moret, N. Charlotte, Peeters, Petra H., Gram, Inger Torhild, Weiderpass, Elisabete, Duell, Eric J., Sanchez, Maria-Jose, Ardanaz, Eva, Etxezarreta, Nerea, Navarro, Carmen, Idahl, Annika, Lundin, Eva, Jirström, Karin, Manjer, Jonas, Wareham, Nicholas J., Khaw, Kay-Tee, Byrne, Karl Smith, Travis, Ruth C., Gunter, Marc J., Merritt, Melissa A., Riboli, Elio, Cramer, Daniel W., Kaaks, Rudolf
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2016
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5026545/
https://ncbi.nlm.nih.gov/pubmed/27060155
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-16-0316
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi